Lilly to Buy Psychedelic Firm AtaiBeckley for Up to $3.8 Billion
Sam Fazeli, Bloomberg Intelligence, Director of Research: Healthcare, Defence, Industrials & Autos, joined Bloomberg's Paul Sweeney and Scarlet Fu to dissect the latest in the biotech sector,...